|
Real-time Estimate
Tradegate
01:24:20 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5.063 EUR | -4.47% |
|
-5.66% | -28.57% |
| 28/08 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold from Speculative Buy; Price Target is AU$10 | MT |
| 27/08 | Clinuvel Pharmaceuticals Limited, 2026 Earnings Call, Aug 27, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.00% | +4.43% | +11.09% | +36.27% | +9.28% | +49.60% | +1.42% | +24.12% | +117.03% | 8.42TCr | ||
| -1.29% | +4.27% | +169.99% | +203.44% | +404.82% | +519.00% | +32.26% | -64.27% | - | 5.94TCr | ||
| -0.57% | +1.27% | +35.45% | +88.47% | +1.07% | -17.24% | -34.99% | -42.94% | +66.32% | 6.05TCr | ||
| -1.60% | -7.34% | +3.79% | +8.05% | -12.86% | -5.08% | +31.05% | +1.01% | - | 5.03TCr | ||
| -1.59% | +0.32% | -2.73% | -16.30% | -8.97% | +6.16% | +165.79% | +120.91% | +193.51% | 4.89TCr | ||
| +0.83% | +1.36% | +11.24% | +14.57% | +27.57% | +58.53% | -15.97% | -32.70% | -28.41% | 3.32TCr | ||
| -0.64% | +0.20% | +8.08% | +30.64% | +29.59% | +47.19% | +97.87% | +68.22% | +56.06% | 2.59TCr | ||
| -0.29% | -4.74% | +18.11% | +34.03% | +34.30% | +2.30% | +196.81% | +54.22% | - | 2.28TCr | ||
| -0.26% | -1.29% | +5.50% | +3.32% | +38.28% | +67.96% | +113.25% | +89.93% | +354.29% | 1.67TCr | ||
| -5.19% | -9.15% | +15.87% | +3.05% | -18.15% | -20.63% | +740.91% | +418.78% | +6,497.46% | 1.45TCr | ||
| -1.42% | -4.16% | -5.69% | +15.16% | -1.41% | +45.47% | +146.60% | +46.09% | - | 1.47TCr | ||
| -0.81% | +1.75% | +10.73% | +21.53% | +11.78% | +12.63% | -28.59% | -21.80% | -30.61% | 1.29TCr | ||
| -0.75% | +1.01% | -1.27% | -10.77% | +14.08% | +70.78% | +155.05% | +680.63% | +2,765.89% | 1.09TCr | ||
| +0.61% | +3.92% | +18.84% | +23.08% | +50.67% | +147.32% | +194.23% | +534.23% | - | 1.1TCr | ||
| -1.75% | -15.93% | +27.36% | +77.95% | +305.77% | +395.04% | +446.31% | +12.20% | - | 807.11Cr | ||
| +0.17% | -0.24% | -2.69% | +9.63% | -7.23% | -19.17% | -21.81% | -52.89% | -48.46% | 691.13Cr | ||
| +0.73% | +0.84% | +9.62% | +68.17% | +95.08% | +126.80% | +353.10% | +553.17% | - | 627.86Cr | ||
| +2.66% | +0.10% | +5.26% | +31.95% | +4.97% | -7.82% | +68.95% | -10.88% | - | 632.88Cr | ||
| +1.01% | -3.62% | +5.10% | +4.34% | +2.31% | +10.93% | +207.17% | +201.40% | - | 560.57Cr | ||
| Average | -0.58% | -1.10% | +18.09% | +34.03% | +51.63% | +78.41% | +149.97% | +135.76% | +994.31% | 2.63TCr | |
| Weighted average by Cap. | -0.89% | +0.56% | +30.30% | +48.57% | +61.22% | +90.49% | +83.37% | +58.19% | +487.97% |
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
- Sector Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















